Over the years, the gilthead seabream (Sparus aurata), a prominent species in Mediterranean aquaculture with an increasing production volume and aquafarming technologies, has become an important research focus. The accumulation of knowledge via several studies during the past decades on their functional and biological characteristics has significantly improved the aquacultural aspects, namely their reproductive success, survival, and growth. Despite the remarkable progress in the aquaculture industry, hatchery conditions are still far from ideal, resulting in frequent challenges at the beginning of intensive culture, entailing significant economic losses. Given its increasing importance and the persistent challenges faced in its aquacultural practices, a thorough review is essential to consolidate knowledge, and elucidate the intricate facets concerning its distribution, life cycle, growth dynamics, genetics, aquaculture methodologies, economic dimensions, and the challenges inherent to its cultivation.

Antimicrobial peptides (AMPs) are found widespread in nature and possess antimicrobial and immunomodulatory activities. Due to their multifunctional properties, these peptides are a focus of growing body of interest and have been characterized in several fish species. Due to their similarities in amino-acid composition and amphipathic design, it has been suggested that neuropeptides may be directly involved in the innate immune response against pathogen intruders. In this review, we report the molecular characterization of the fish-specific AMP piscidin1, the production of an antibody raised against this peptide and the immunohistochemical identification of this peptide and enkephalins in the neuroepithelial cells (NECs) in the gill of several teleost fish species living in different habitats. In spite of the abundant literature on Piscidin1, the biological role of this peptide in fish visceral organs remains poorly explored, as well as the role of the neuropeptides in neuroimmune interaction in fish. The NECs, by their role as sensors of hypoxia changes in the external environments, in combination with their endocrine nature and secretion of immunomodulatory substances would influence various types of immune cells that contain piscidin, such as mast cells and eosinophils, both showing interaction with the nervous system. The discovery of piscidins in the gill and skin, their diversity and their role in the regulation of immune response will lead to better selection of these immunomodulatory molecules as drug targets to retain antimicrobial barrier function and for aquaculture therapy in the future.

The brain-derived neurotrophic factor (BDNF) was discovered in the last century, and identified as a member of the neurotrophin family. BDNF shares approximately 50% of its amino acid with other neurotrophins such as NGF, NT-3 and NT-4/5, and its linear amino acid sequences in zebrafish (Danio rerio) and human are 91% identical. BDNF functions can be mediated by two categories of receptors: p75NTR and Trk. Intriguingly, BDNF receptors were highly conserved in the process of evolution, as were the other NTs’ receptors. In this review, we update current knowledge about the distribution and functions of the BDNF-TrkB system in the sensory organs of zebrafish. In fish, particularly in zebrafish, the distribution and functions of BDNF and TrkB in the brain have been widely studied. Both components of the system, associated or segregated, are also present outside the central nervous system, especially in sensory organs including the inner ear, lateral line system, retina, taste buds and olfactory epithelium.

Central nervous system disorders represent a heterogeneous set of conditions triggered by genetic alterations, environmental exposures, infections, injuries, and even iatrogenic causes. These conditions impact a significant portion of the global population, posing serious concerns for public health. Even though progress has been made in understanding and treating some of these disorders, many others remain poorly understood, with research still in their early stages. For that, adapted experimental models are essential for deciphering the physiopathology of disorders and developing future therapeutic strategies. Within this context, zebrafish (Danio rerio) has emerged as a valuable model for central nervous system disorders, thanks to its high genetic and neuroanatomical homology with humans, the conservation in different aspects of cellular architecture and blood–brain barrier, and the remarkable regenerative ability of the CNS. This review presents the state of the art on zebrafish models for central nervous system disorders, presenting their potential in comprehending the pathophysiological processes and screening therapeutics.